Pharmaceutical leader Reliant wanted to license the rights to a drug product with limited portfolio fit. IntraLinks provided a more efficient way to reach a wider range of potential partners than traditional due diligence methods. This afforded more time to Reliant executives to concentrate on their business while numerous suitors evaluated the deal.

Reliant called on IntraLinks to improve its due diligence process. The company had been introduced to IntraLinks Exchanges while considering the purchase of an asset from another pharmaceutical company. It was impressed by the security and ease of use of IntraLinks’ on-demand solution.

To read the complete case study please click here.